Filter
2543
Filtered Results: 2543
Text search:
prophylaxis
Featured
Recommendations
248
New Publications
712
Language
Document type
No document type
1586
Guidelines
438
Studies & Reports
245
Manuals
102
Strategic & Response Plan
53
Fact sheets
49
Training Material
29
Infographics
16
Situation Updates
12
Brochures
6
Resource Platforms
4
Online Courses
2
Dashboards/Maps
1
Countries / Regions
India
140
Kenya
84
South Africa
76
Tanzania
54
Ethiopia
54
Malawi
48
Rwanda
45
Global
45
Zambia
44
Germany
42
Uganda
41
Nigeria
39
Namibia
39
Nepal
38
Congo, Democratic Republic of
34
Western and Central Europe
32
Liberia
32
Senegal
31
Africa
30
Lesotho
26
Sierra Leone
25
Ghana
24
Latin America and the Carribbean
23
Zimbabwe
22
Burkina Faso
18
Asia
18
Madagascar
18
Ukraine
17
Botswana
17
Haiti
16
Bangladesh
16
Benin
15
Cameroon
15
Philippines
15
Russia
15
Cambodia
13
Myanmar / Burma
13
Mozambique
11
Eastern Europe
11
Syria
9
Brazil
9
East and Southern Africa
8
Central African Republic
8
Indonesia
8
Eswatini/ Swaziland
8
Guinea
7
South–East Asia Region
6
Pakistan
6
West and Central Africa
5
Georgia
5
North Macedonia
4
Peru
4
USA
4
Paraguay
4
Argentina
4
South Sudan
4
Armenia
3
Middle East and North Africa
3
Western Pacific Region
3
Vietnam
3
Sri Lanka
3
Angola
3
Thailand
2
Togo
2
Albania
2
Laos
2
Niger
2
Afghanistan
2
Guinea-Bissau
2
Eastern Europe and Central Asia
2
Belgium
2
France
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Yemen
2
Bhutan
2
Tajikistan
1
Switzerland
1
Colombia
1
Gambia
1
Canada
1
Fiji
1
Burundi
1
Malaysia
1
Austria
1
Qatar
1
Bulgaria
1
Mauritania
1
Jordan
1
Saudi Arabia
1
Denmark
1
Portugal
1
Belarus
1
Southern Africa
1
Bolivia
1
Lebanon
1
Moldova
1
Egypt
1
Romania
1
Mali
1
Chad
1
Libya
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1013
Clinical Guidelines
290
Women & Child Health
158
Public Health
73
Key Resources
52
Capacity Building
49
Pharmacy & Technologies
19
Toolboxes
HIV
559
TB
136
COVID-19
113
AMR
110
Rapid Response
90
Pharmacy
74
Caregiver
73
Ebola
56
NTDs
52
Refugee
47
Mental Health
44
Conflict
39
Specific Hazards
21
Planetary Health
17
Polio
17
Global Health Education
11
Zika
10
Disability
9
NCDs
8
Natural Hazards
7
Cholera
5
Health Financing Toolbox
5
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
This technical brief aims to support these trends, accelerated by the COVID-19 pandemic, and improve PrEP uptake, persistence, and effective use by providing implementation guidance for differentiated and simplified service delivery. The brief aims to support a range of stakeholders in planning and ...
Rabies is a neglected zoonotic disease with a global burden of approximately 59,000 human deaths a year. Once clinical symptoms appear, rabies is almost invariably fatal; however, with timely and appropriate post-exposure prophylaxis (PEP) consisting of wound washing, vaccine, and in some cases rabi...
WHO strongly recommends discontinuation of the nerve tissue vaccine, and replacement with modern concentrated and purified cell culture derived vaccines (CCDV) and embryonated eggbased rabies vaccines.
These vaccines must comply with WHO criteria for potency and innocuity following satisfactory ass...
Evidence shows that oral pre-exposure prophylaxis (PrEP) reduces the risk of contracting HIV during sexual intercourse by more than 90% when taken daily. It is for this reason the National HIV Prevention Strategy 2015-2020 (2018 Revision) emphasises the role of preexposure prophylaxis (PrEP) in ...
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti...
Rabies is a public health problem in Asia and vaccine affordability is an issue.
There is no reduction in the number of persons seeking post-exposure prophylaxis.
The high cost of cell culture vaccines for intramuscular use is a limiting factor.
Intradermal rabies vaccination offers cost-effectiv...
This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing thirty key questions about PrEP and how it might be implemented in the UK.
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infe...
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing...
Rabies is 100% fatal but also 100% preventable with prompt and complete post-exposure prophylaxis (PEP). All animal bites, scratches and licks must be assessed for potential rabies virus exposure.
Eine Leitlinie zur Diagnostik und Therapie, einschließlich Chemoprävention und -prophylaxe des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose e.V. im Auftrag der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.
Tuberculosis Guideline for Adults
Guideline for Diagnosis...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at red...
